|
| 华曙高科(688433)限售解禁 | | 解禁日期 | 本期流通股本
(万股) | 本期流通股本占
总股本比例(%) | 已流通股本
(万股) | 未流通股本
(万股) | 流通A股
(万股) | 流通A股占
总股本比例(%) | 限售股类型 | | 2025-04-17 | 165.73 | 0.40% | 20210.43 | 21206.45 | 3720.52 | 8.98% | 首发战略配售股份 | | 2024-12-30 | 1273.65 | 3.08% | 20044.70 | 21372.18 | 3720.52 | 8.98% | 首发原股东限售股份 | | 2024-09-27 | 621.32 | 1.50% | 18771.05 | 22645.83 | 3720.52 | 8.98% | 首发原股东限售股份 | | 2024-08-12 | 409.64 | 0.99% | 18149.72 | 23267.16 | 3720.52 | 8.98% | 首发原股东限售股份 | | 2024-06-21 | 828.50 | 2.00% | 17740.08 | 23676.80 | 3720.52 | 8.98% | 首发原股东限售股份 | | 2024-04-17 | 13191.06 | 31.85% | 16911.58 | 24505.30 | 3720.52 | 8.98% | 首发原股东限售股份,首发战略配售股份 | | 2023-10-17 | 264.97 | 0.64% | 3759.36 | 37657.52 | 3494.39 | 8.44% | 首发机构配售股份 | | 2023-04-17 | 3455.55 | -- | -- | 37961.33 | -- | -- | 首发一般股份 |
|